Can Fentanyl Lead to Opioid-induced Hyperalgesia in Healthy Volunteers?
NCT02252458 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21
Last updated 2015-01-09
Summary
The purpose of this study is to examine whether two clinically sensible dose regimen of fentanyl (low dose vs. high dose) lead to different pain scores as measured by the nonverbal rating scale (NRS) in healthy volunteers at 4.5 to 6.5 hours after fentanyl application. Pain modalities tested will include transdermal electrical stimulation and cold pressor pain.
The investigators hypothesize that the high dose fentanyl group will have an increase of approximately 20% in the NRS.
Conditions
- Healthy
Interventions
- DRUG
Sponsors & Collaborators
-
University Hospital, Basel, Switzerland
lead OTHER
Principal Investigators
-
Wilhelm Ruppen, PD Dr., MD · University Hospital Basel, Dep. of Anesthesia
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-08-31
- Primary Completion
- 2015-01-31
- Completion
- 2015-01-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Determination of Analgesic Equipotent Doses of Inhaled Metoxyflurane vs. Intravenous Fentanyl
NCT03894800 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Compare Patient-controlled Pain Medications Delivered Either Through the Skin or Intravenously
NCT00996177 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Opioids on Experimental Hyperalgesia in Oesophagus, Skin and Muscles
NCT00489684 ·Status: COMPLETED
-
Analgesic Tolerance to Repeated Doses of Subcutaneous Morphine
NCT00256347 ·Status: COMPLETED ·Phase: NA
-
Fentanyl Matrix Application for Cancer Pain: Multicenter, Prospective, Observational Study
NCT01816503 ·Status: COMPLETED
-
Impact of Naloxone on the Analgesic Effect of Paracetamol in Healthy Volunteers
NCT00750048 ·Status: COMPLETED ·Phase: PHASE1
-
Phase III Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Chronic Intractable Pain- Assessment of Effectiveness, Safety and Pharmacokinetics
NCT00216684 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain
NCT00214955 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Use and Safety of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer
NCT00269763 ·Status: COMPLETED ·Phase: PHASE3
-
Fentanyl vs. Low-Dose Ketamine for the Relief of Moderate to Severe Pain in Aeromedical Patients
NCT01169025 ·Status: WITHDRAWN ·Phase: NA
-
Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -
NCT00216658 ·Status: COMPLETED ·Phase: PHASE2
-
Sublingual Fentanyl for the Management of Breakthrough Pain
NCT02514252 ·Status: TERMINATED ·Phase: PHASE2
-
Safety of Intranasal Fentanyl (PecFent®) in the Treatment of Procedural Pain in the Elderly
NCT02298582 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Relative Bioavailability Study of Fentanyl 25 μg/h Transdermal System
NCT00864565 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of Fentanyl Transdermal (Fentanest®)
NCT00959400 ·Status: WITHDRAWN ·Phase: PHASE3
-
Effectiveness and Tolerance of Fentanyl Citrate in Painful Pain Induced During Diagnostic or Therapeutic Examinations in Cancer Patients
NCT03809455 ·Status: WITHDRAWN ·Phase: PHASE2
-
Efficacy of Fentanyl to Reduce the Time of Severe Postoperative Pain Relief Compared to Morphine
NCT02145975 ·Status: COMPLETED ·Phase: PHASE3
-
Opioid Titration With 12.5 ug/h Fentanyl Transdermal Patch vs Orally Morphine for Opioid-naïve Patients With Moderate Cancer Pain
NCT04533243 ·Status: UNKNOWN ·Phase: PHASE3
-
Optimizing Subcutaneous FEntanyl titRation: RApid Achievement of Adequate Exposure When Treating Cancer-Related paIn.
NCT06498037 ·Status: RECRUITING ·Phase: PHASE4
-
Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain
NCT00214942 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer Pain
NCT00236327 ·Status: TERMINATED ·Phase: PHASE4
-
Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hr
NCT00648414 ·Status: TERMINATED ·Phase: PHASE1
-
Correlation Between the Analgesic Effect of Fentanyl Transdermal Patches and Nutritional Status in Cancer Pain Patients
NCT06369961 ·Status: COMPLETED
-
The Effectiveness and Tolerability of Fentanyl Matrix in Chronic Non-cancer Pain; Assessment of Patient's Pain Treatment Goal Achievement
NCT01688583 ·Status: COMPLETED
-
Side Effects of a Single Shot Intrathecal Morphine in Clinical Practice, a Retrospective Analysis
NCT07238179 ·Status: ACTIVE_NOT_RECRUITING